Michael Marberger
Overview
Explore the profile of Michael Marberger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
145
Citations
3904
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanghvi N, Chen W, Carlson R, Weis C, Seip R, Uchida T, et al.
J Ther Ultrasound
. 2017 Sep;
5:24.
PMID: 28924476
Background: The purpose of these clinical studies was to validate a Tissue Change Monitoring (TCM) algorithm in vivo. TCM is a quantitative tool for the real-time assessment of HIFU dose....
2.
Ribal M, Mengual L, Lozano J, Ingelmo-Torres M, Palou J, Rodriguez-Faba O, et al.
Eur J Cancer
. 2016 Jan;
54:131-138.
PMID: 26761785
Objective: This study aimed to validate, in a prospective, blinded, international and multicenter cohort, our previously reported four non-invasive tests for bladder cancer (BC) diagnosis based on the gene expression...
3.
Cuzick J, Thorat M, Andriole G, Brawley O, Brown P, Culig Z, et al.
Lancet Oncol
. 2014 Oct;
15(11):e484-92.
PMID: 25281467
Prostate cancer is a common malignancy in men and the worldwide burden of this disease is rising. Lifestyle modifications such as smoking cessation, exercise, and weight control offer opportunities to...
4.
Andriole G, Bostwick D, Gomella L, Marberger M, Montorsi F, Tammela T, et al.
Urology
. 2014 Jun;
84(2):393-9.
PMID: 24916669
Objective: To explore explanations for the numerical imbalance of biopsy-detected Gleason 8-10 prostate cancers (PCa) diagnosed in years 3-4 in the dutasteride and placebo groups of the Reduction by Dutasteride...
5.
Schmitz-Drager B, Schoffski O, Marberger M, Sahin S, Schmid H
Recent Results Cancer Res
. 2014 Feb;
202:79-91.
PMID: 24531781
A high disease prevalence, the presentation in older age, a frequently slowly progressing course of disease, and high costs make diagnosis and therapy of prostate cancer a special challenge for...
6.
Muller B, Futterer J, Gupta R, Katz A, Kirkham A, Kurhanewicz J, et al.
BJU Int
. 2013 Nov;
113(2):218-27.
PMID: 24215670
Objective: To establish a consensus on the utility of multiparametric magnetic resonance imaging (mpMRI) to identify patients for focal therapy. Methods: Urological surgeons, radiologists, and basic researchers, from Europe and...
7.
Muller B, van den Bos W, Brausi M, Cornud F, Gontero P, Kirkham A, et al.
BJU Int
. 2013 Nov;
114(5):698-707.
PMID: 24180365
Objective: To define the role of multiparametric MRI (mpMRI) for treatment planning, guidance and follow-up in focal therapy for prostate cancer based on a multidisciplinary Delphi consensus project. Materials And...
8.
Schoenthaler M, Buchholz N, Farin E, Ather H, Bach C, Bach T, et al.
World J Urol
. 2013 Oct;
32(4):1033-40.
PMID: 24135917
Purpose: The Post-Ureteroscopic Lesion Scale (PULS) offers a simple grading system for the description of ureteral lesions after ureteroscopy. In this article, we present the results of a video-based multicenter...
9.
Tsivian M, Rampersaud Jr E, Pes M, Joniau S, Leveillee R, Shingleton W, et al.
BJU Int
. 2013 Oct;
113(6):854-63.
PMID: 24119037
To discuss the use of renal mass biopsy (RMB) for small renal masses (SRMs), formulate technical aspects, outline potential pitfalls and provide recommendations for the practicing clinician. The meeting was...
10.
Mulders P, Molina A, Marberger M, Saad F, Higano C, Chi K, et al.
Eur Urol
. 2013 Oct;
65(5):875-83.
PMID: 24099659
Background: Metastatic castration-resistant prostate cancer (mCRPC) is a disease that primarily affects older men. Abiraterone acetate (AA), a selective androgen biosynthesis inhibitor, in combination with low-dose prednisone (P) improved overall...